SELECTIVE INHIBITION BY DANAZOL OF FOLLICLE STIMULATING HORMONE DURING THE LUTEAL PHASE

Brian A. Lieberman, Sophie Pluta Thom, M. A. F. Murray, H. S. Jacobs
In: BJOG: An International Journal of Obstetrics & Gynaecology · 1977 · vol. 84(1) , pp. 55–57 · doi:10.1111/j.1471-0528.1977.tb12468.x · PMID:321001 · W2025738652
article OA: closed CC0 ⤵ 13 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Daily danazol administration during the luteal phase selectively impaired the follicle-stimulating hormone response to LHRH in normally menstruating women without affecting other hormonal levels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In each of six healthy, normally menstruating women, serum oestradiol, progesterone, basal and post luteinizing hormone releasing hormone (LHRH) gonadotrophin measurements were made during the luteal phase of a normal cycle and in a subsequent cycle in which 800 mg of danazol was given daily from the fifth day after the presumptive date of ovulation. No differences in the serum oestradiol, progesterone, or basal gonadotrophin levels were detected, but there was a selective impairment of the follicle stimulating hormone response to LHRH. The implications of these findings are discussed.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (11)

Cited by (12)

Source provenance

openalex
last seen: 2026-05-10T10:38:32.911278+00:00
unpaywall
last seen: 2026-08-17T06:25:09.426038+00:00
License: CC0 · commercial use OK